跳到正文
原文
Bristol Myers Squibb· @bmsnews · X·· 11 天前精选AI 评分58
AI 导读

百时美施贵宝在#HCMSCHICAGO上公布其针对儿童症状性梗阻性肥厚型心肌病(oHCM)的III期试验56周阳性结果,并称该结果强化并延续了此前报告的发现。相关数据同时在#AHA2026上分享,详细结果见链接。

推荐理由

百时美施贵宝公布儿童症状性梗阻性肥厚型心肌病III期试验56周阳性结果,为这一人群的用药提供更长随访数据。

正文

#MEDIA: At #HCMSCHICAGO, we shared new positive 56-week results from our Phase 3 trial in pediatric patients living with symptomatic obstructive hypertrophic cardiomyopathy (oHCM), reinforcing and building on previously reported findings: https://bit.ly/4zaupzp #AHA2026

来源:Bristol Myers Squibb · x.com